Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice
- PMID: 28720455
- PMCID: PMC5883214
- DOI: 10.1016/j.pvr.2017.01.002
Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice
Abstract
Despite the effectiveness and availability of the Human Papillomavirus (HPV) vaccine, HPV remains the most common sexually transmitted infection in the United States and has the lowest initiation rate of any routinely recommended teen vaccine. In January 2015, we surveyed parents at a Southern California pediatric private practice about reasons they accept or refuse HPV vaccine for their children. Of the 200 consecutive parents that had HPV vaccine initiation recommended for their child, 123 (61.5%) children were male and 38.5% were female. The overall age range of children was 10-17 years (median 12 years). Of the 164 (82.0%) who accepted the vaccine, a higher percentage were male (88.6% vs 71.4%, p=0.001). The most common reasons for accepting was strength of provider recommendation (84.1%) and available information (63.4%). The most common (52.8%) reason for refusing was wanting to learn more about the vaccine. These results further support the importance of both the strength of physician recommendation and improving public education about the vaccine.
Keywords: Acceptability; HPV; HPV Vaccine; Physician Recommendation.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Factors associated with parental reasons for "no-intent" to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008-2012.BMC Pediatr. 2017 Feb 13;17(1):52. doi: 10.1186/s12887-017-0804-1. BMC Pediatr. 2017. PMID: 28193249 Free PMC article.
-
Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.Hum Vaccin Immunother. 2016 Jun 2;12(6):1519-27. doi: 10.1080/21645515.2016.1157673. Epub 2016 Mar 22. Hum Vaccin Immunother. 2016. PMID: 27003108 Free PMC article.
-
Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons.Vaccine. 2014 Jun 30;32(31):3883-5. doi: 10.1016/j.vaccine.2014.05.035. Epub 2014 May 18. Vaccine. 2014. PMID: 24844150
-
Human Papillomavirus Infection and Vaccination.J Pediatr Nurs. 2016 Mar-Apr;31(2):e155-66. doi: 10.1016/j.pedn.2015.10.005. Epub 2015 Nov 14. J Pediatr Nurs. 2016. PMID: 26586310 Review.
-
Improving adolescent health: focus on HPV vaccine acceptance.J Adolesc Health. 2005 Dec;37(6 Suppl):S17-23. doi: 10.1016/j.jadohealth.2005.09.010. J Adolesc Health. 2005. PMID: 16310137 Review.
Cited by
-
Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine.BMC Med Inform Decis Mak. 2022 Dec 22;22(1):339. doi: 10.1186/s12911-022-02083-2. BMC Med Inform Decis Mak. 2022. PMID: 36550466 Free PMC article.
-
A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices.Implement Sci. 2019 Mar 14;14(1):30. doi: 10.1186/s13012-019-0871-9. Implement Sci. 2019. PMID: 30866981 Free PMC article.
-
Assessment of Human Papillomavirus Vaccine Knowledge and Attitudes Among Adolescent School Girls in Debre Berhan City, Ethiopia: A Community-Based Cross-Sectional Study.Health Sci Rep. 2025 Feb 24;8(2):e70506. doi: 10.1002/hsr2.70506. eCollection 2025 Feb. Health Sci Rep. 2025. PMID: 39995791 Free PMC article.
-
Ancillary Benefit of Increased HPV Immunization Rates Following a CBPR Approach to Address Immunization Disparities in Younger Siblings.J Community Health. 2019 Jun;44(3):544-551. doi: 10.1007/s10900-018-00610-9. J Community Health. 2019. PMID: 30604221 Free PMC article.
-
HPV vaccination discourses and the construction of "at-risk" girls.Can J Public Health. 2018 Dec;109(5-6):622-632. doi: 10.17269/s41997-018-0108-8. Epub 2018 Aug 3. Can J Public Health. 2018. PMID: 30076535 Free PMC article.
References
-
- Satterwhite C.L., Torrone E., Meites E., Dunne E.F., Mahajan R., Ocfemia M.C. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm. Dis. 2013;40(3):187–193. - PubMed
-
- de Sanjose S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–1056. - PubMed
-
- Lacey C.J., Lowndes C.M., Shah K.V. Chapter 4: burden and management of non-cancerous HPV-related conditions: hpv-6/11 disease. Vaccine. 2006;24(Suppl 3):S3/35–41. - PubMed
-
- Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6(4):204. - PubMed
-
- Reagan-Steiner S., Yankey D., Jeyarajah J. immunization services division, National Center for immunization and respiratory diseases; Center for disease control and prevention (CDC). National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2015. MMWR Morb. Mortal. Wkly Rep. 2016;65(33):850–858. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical